UPDATE 2-Aquinox to stop development of lead drug; shares plunge
June 27, 2018 at 10:42 AM EDT
June 27 (Reuters) - Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.
